Brain‐to‐Blood Transport of Peptides and the Alcohol Withdrawal Syndrome

Annals of the New York Academy of Sciences

Volumn 739, Issue 1, 1994, Pages 108-118

  BANKS, WILLIAM A ^a   KASTIN, ABBA J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ARGIPRESSIN; BRAIN PROTEIN; GONADORELIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LEUCINE ENKEPHALIN; METENKEPHALIN; OXYTOCIN; PANCREAS POLYPEPTIDE; TYROSYLPROLYLLEUCYLGLYCINAMIDE; VAPREOTIDE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN FUNCTION; BRAIN METABOLISM; CONFERENCE PAPER; HORMONE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; NONHUMAN; PROTEIN TRANSPORT;

ANIMALIA;

EID: 0028658286     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1994.tb19812.x     Document Type: Article

References (78)

1. The choroid plexus‐arachnoid membrane‐cerebrospinal fluid system
2. Serum proteins by‐pass the blood‐brain barrier for extracellular entry to the central nervous system
3. Comparison of lipid‐mediated blood‐brain barrier penetrability in neonates and adults
4. Some special aspects of the blood‐brain barrier
5. Brain uptake of radio‐labelled amino acids, amines and hexoses after arterial injection
6. Blood‐brain‐CSF relations
7. The return of the cerebrospinal fluid to the blood. The drainage mechanism
8. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat
9. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation
10. Cervical lymphatics, the blood–brain barrier and the immunoreactivity of the brain: A new view
11. Transport of potassium at the blood‐brain barrier
12. Ventriculo‐cisternal perfusion of twelve amino acids in the rabbit
13. Transport of neutral amino acids from feline cerebrospinal fluid
14. Brain serotonin content: Physiological dependence on plasma tryptophan levels
15. Polarity of the blood‐brain barrier: Neutral amino acid transport into isolated brain capillaries
16. Drug transport in the central nervous system: Role of carriers
17. 131I across the blood‐brain barrier
18. Factors affecting distribution of iodide in brain and cerebrospinal fluid
19. The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicylic acid and iodide
20. Ceftriaxone transport through the blood‐brain barrier
21. Efflux of cimetidine from the rat cerebrospinal fluid
22. Transport of thyroxine across the blood‐brain barrier is directed primarily from brain to blood in the mouse
23. 4 in the critically ill hypothyroid patient: Evaluation of transport across the blood‐brain barrier in a primate model
24. P‐glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
25. Multidrug‐resistance gene (P‐glycoprotein) is expressed by endothelial cells at blood‐brain barrier sites
26. The passage of certain substances out of the cerebrospinal fluid
27. The transport of encephalins from the cerebrospinal fluid of the rabbit
28. Carrier‐mediated transport of enkephalins and N‐Tyr‐MIF‐1 across blood‐brain barrier
29. Carrier‐mediated transport of vasopressin across the blood‐brain barrier of the mouse
30. Isolation of metabolically active capillaries from rat brain
31. Bovine brain microvessel endothelial cell monolayers as a modei system for the blood‐brain barrier. In Biological Approaches to the Controlled Delivery of Drugs
32. Permeability of the blood‐brain barrier to peptides: An approach to the development of therapeutically useful analogs
33. 1]‐Peptide T‐amide is transported from blood to brain by a saturable system
34. 1‐28 (Alzheimer's disease protein)
35. Radioactively iodinated cyclo(His‐Pro) crosses the blood‐brain barrier and reverses ethanol‐induced narcosis
36. Differential clearance of neurophysin and neurohypophysial peptides from the cerebrospinal fluid in conscious guinea pigs
37. Penetration of neurohypophysial hormones from plasma intocerebrospinal fluid (CSF): Half‐times of disappearance of these neuropeptides from CSF
38. Clearance of vasopressin from cerebrospinal fluid to blood in chronically cannualated Brattleboro rats
39. Central mechanism of vasopressin‐induced changes in antidiuretic hormone release
40. Bidirectional saturable transport of LHRH across the blood–brain barrier
41. Effects of various reproductive hormones on the penetration of LHRH across the blood‐brain barrier
42. Permeability of the murine blood‐brain barrier to some octapeptide analogs of somatostatin
43. Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research
44. Pituitary adenylate cyclase activating polypeptide (PACAP) potentiates the gonadotropin‐releasing activity of luteinizing hormonereleasing hormone
45. Two high‐affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions
46. Pituitary adenylate cyclase activating polypeptide (PACAP) can cross the vascular component of the blood‐testis barrier in the mouse
47. Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes
48. PACAP stimulates cAMP accumulation and secretory function in cultured rat sertoli cells
49. Differential effect of aluminum on the blood‐brain barrier transport of peptides, technetium and albumin
50. Modulation of the carrier‐mediated transport of the Tyr‐MIF‐1 across the blood‐brain barrier by essential amino acids
51. Leucine modulates peptide transport system‐1 across the blood‐brain barrier at a stereospecific site within the central nervous system
52. Effect of neurotransmitters on the system that transports Tyr‐MIF‐1 and the enkephalins across the blood‐brain barrier: A dominant role for serotonin
53. Twenty‐one hormones fail to inhibit the brain to blood transport system for Tyr‐MIF‐1 and the enkephalins in mice
54. Inhibition of the brain to blood transport system for enkephalins and Tyr‐MIF‐1 in mice addicted or genetically predisposed to drinking ethanol
55. Passage of Tyr‐MIF‐1 from blood to brain
56. Kinetic analysis of leucine‐enkephalin cellular uptake at the luminal side of the blood‐brain barrier of an in situ perfused guinea pig brain
57. Blood‐brain barrier restriction of peptides and the low uptake of enkephalins
58. Editorial review: Peptide transport systems for opiates across the blood‐brain barrier
59. Effects of neonatal treatment with Tyr‐MIF‐1, morphiceptin, and morphine on development, tail flick, and blood‐brain barrier transport
60. Aging and the blood‐brain barrier: Changes in the carrier‐mediated transport of peptides in rats
61. Analgesia and the blood‐brain barrier transport system for Tyr‐MIF‐1/enkephalins: Evidence for a dissociation
62. 2 receptor in the pentobarbital anesthetized mouse model
63. Ethanol acceptance as a function of genotype amounts of brain [met]‐enkephalin
64. Opioid peptides and genotypic responses to ethanol
65. Regional brain [Met]‐enkephalin in alcohol‐preferring and non‐alcohol‐preferring inbred strains of mice
66. Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary
67. Enkephalinase inhibition: Regulation of ethanol intake in genetically predisposed mice
68. Suppression of ethanol consumption by MET‐enkephalin in rats
69. 5‐enkephalinamide impairs the acquisition of ethanol preference without influencing sucrose preference
70. Alcohol dependence and withdrawal and brain endorphins
71. Effects of the 5‐HT receptor agonist, 8‐OH‐DPAT, on ethanol preference in the rat
72. The potential for alcohol to affect the passage of peptide and protein hormones across the blood‐brain barrier: A hypothesis for a disturbance in brain‐body communication
73. Reduction in cerebral methionine‐enkephalin content during the ethanol withdrawal syndrome
74. Transport, uptake, and metabolism of blood‐borne vasopressin by the blood‐brain barrier